Steve Hazell

4.4k total citations
15 papers, 332 citations indexed

About

Steve Hazell is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Neurology. According to data from OpenAlex, Steve Hazell has authored 15 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 3 papers in Neurology. Recurrent topics in Steve Hazell's work include Testicular diseases and treatments (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). Steve Hazell is often cited by papers focused on Testicular diseases and treatments (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). Steve Hazell collaborates with scholars based in United Kingdom. Steve Hazell's co-authors include Ayoma D. Attygalle, Nandita M. deSouza, Veronica A. Morgan, Thomas Ind, Eric O. Aboagye, Stephen Mangar, Amarnath Challapalli, David J. Collins, Jessica Winfield and Matthew Orton and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Steve Hazell

15 papers receiving 328 citations

Peers

Steve Hazell

PRM

RNMI

ONCOL

Yukihisa Tamaki Japan

Shahin Shajahan United States

Anupama Chundury United States

Izaskun Valduvieco Spain

Douglas G. Gold United States

Sophie Bockel France

Melissa Christiaens Belgium

E. Van Limbergen Belgium

Fuki Shitano Japan

Giulio Alberto Carta Italy

Yukihisa Tamaki Japan

Steve Hazell

177 ×1.1

PRM

157 ×1.1

RNMI

33 ×0.5

25 ×0.4

67 ×1.3

ONCOL

Citations per year, relative to Steve Hazell Steve Hazell (= 1×) peers Yukihisa Tamaki

Countries citing papers authored by Steve Hazell

Since Specialization

Citations

This map shows the geographic impact of Steve Hazell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Hazell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Hazell more than expected).

Fields of papers citing papers by Steve Hazell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Hazell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Hazell. The network helps show where Steve Hazell may publish in the future.

Co-authorship network of co-authors of Steve Hazell

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Hazell. A scholar is included among the top collaborators of Steve Hazell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Hazell. Steve Hazell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Robinson, Elizabeth, Netty Kinsella, Derfel ap Dafydd, et al.. (2025). Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume. The Prostate. 85(8). 784–791. 3 indexed citations

Nicol, Dianne, et al.. (2020). Minimally invasive retroperitoneal lymph node dissection (MI-RPLND) and single dose adjuvant carboplatin for low volume stage 2 seminoma – 3 year outcomes. European Urology Open Science. 19. e397–e397. 1 indexed citations

Huddart, Robert, et al.. (2020). MP11-05 OUTCOMES WITH MINIMALLY INVASIVE RETROPERITONEAL LYMPH NODE DISSECTION (MI-RPLND) AND SINGLE DOSE CARBOPLATIN IN CLINICAL STAGE 2 SEMINOMA. The Journal of Urology. 203. e136–e137. 1 indexed citations

Murray, Julia, Alison Tree, Aslam Sohaib, et al.. (2019). Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial. International Journal of Radiation Oncology*Biology*Physics. 106(4). 715–724. 39 indexed citations

Huddart, Robert, et al.. (2019). Clinical Outcomes of Minimally Invasive Retroperitoneal Lymph Node Dissection and Single Dose Carboplatin for Clinical Stage 2a Seminoma. European Urology Supplements. 18(4). 24–24. 2 indexed citations

Dolly, Saoirse, Cristina Migali, Nina Tunariu, et al.. (2017). Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy. ESMO Open. 2(1). e000101–e000101. 8 indexed citations

Winfield, Jessica, Matthew Orton, David J. Collins, et al.. (2016). Separation of type and grade in cervical tumours using non-mono-exponential models of diffusion-weighted MRI. European Radiology. 27(2). 627–636. 65 indexed citations

Stares, Mark, Samra Turajlic, Andrew J.S. Furness, et al.. (2016). ADAPTeR: A phase II study of anti-PD1 (nivolumab) therapy as pre- and post-operative therapy in metastatic renal cell carcinoma.. Journal of Clinical Oncology. 34(15_suppl). TPS4583–TPS4583. 5 indexed citations

Challapalli, Amarnath, Sebastian Trousil, Steve Hazell, et al.. (2015). Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer. Journal of Clinical Pathology. 68(9). 703–709. 20 indexed citations

10.

Boussios, Stergios, Ayoma D. Attygalle, Steve Hazell, et al.. (2015). Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature Review.. PubMed. 35(12). 6713–22. 41 indexed citations

11.

Shepherd, John H., Ayoma D. Attygalle, Steve Hazell, et al.. (2014). Preoperative imaging in patients undergoing trachelectomy for cervical cancer: Validation of a combined T2- and diffusion-weighted endovaginal MRI technique at 3.0T. Gynecologic Oncology. 133(2). 326–332. 20 indexed citations

12.

Thway, Khin, Steve Hazell, Susana Banerjee, & Cyril Fisher. (2014). Rhabdomyosarcoma with Pseudolipoblasts Arising in Ovarian Carcinosarcoma: A Distinctive Postchemotherapy Morphologic Variant Mimicking Pleomorphic Liposarcoma. SHILAP Revista de lepidopterología. 2014. 1–5. 3 indexed citations

13.

Fisher, Rosalie, Andrew Rowan, Mark Stares, et al.. (2014). A-PREDICT: A phase II study of axitinib in patients with metastatic renal cell cancer unsuitable for nephrectomy (CRUKE/11/061).. Journal of Clinical Oncology. 32(15_suppl). TPS4597–TPS4597. 1 indexed citations

14.

Shenjere, Patrick, et al.. (2014). Melanoma With Rhabdomyosarcomatous Differentiation. International Journal of Surgical Pathology. 22(6). 512–519. 27 indexed citations

15.

Contractor, Kaiyumars, Amarnath Challapalli, Tara Barwick, et al.. (2011). Use of [11C]Choline PET-CT as a Noninvasive Method for Detecting Pelvic Lymph Node Status from Prostate Cancer and Relationship with Choline Kinase Expression. Clinical Cancer Research. 17(24). 7673–7683. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact